Hebrews: Jesus Is Better | Better Rest
Hebrews 4:1-13 - Michael Abrams, Lead Pastor
Hebrews: Jesus Is Better | Better Things
Hebrews 5:11-6:12 - Michael Abrams, Lead Pastor
Exploring Cyanotype Printing and Mushrooms with Madge Evers
Madge Evers (b. 1961, Norwalk, CT) explores the transformative cycles of dormancy, decay, and ecstatic growth in plant life. Her work combines alternative photography, mushroom spores, and painting to depict landscape details and imagined flora.
Evers earned a BA from Suffolk University in Bosto...
Hebrews: Jesus Is Better | The Better Covenant
Hebrews 8:1-13 - Michael Abrams, Lead Pastor
Hebrews: Jesus Is Better | The Better Reward
Hebrews 10:26-39 - Michael Abrams, Lead Pastor
The Table: The Hospitality of God
Genesis 3:9-21, 16:1-15; Psalm 23:5 - Michael Abrams, Lead Pastor
EP 466 | When Experience Becomes an Advantage: Evolving Your Interior Design Firm with Michael Abrams & Gina Valenti
After decades in business, many interior designers reach a quiet crossroads: Is this as good as it gets? In this thoughtful, grounded conversation, Kimberley Seldon sits down with Michael Abrams and Gina Valenti to explore what it really looks like to evolve a design firm after 25 years—without c...
“What’s The Point of Killing Me?”: BEATLE George STABBED in His Home
As always, thank you for hanging out and remembering George Harrison and Olivia Harrison with me today.
In December 1999, former Beatles guitarist George Harrison and his wife Olivia Harrison survived a terrifying home invasion at their estate in Henley-on-Thames, England. In the middle of the n...
Michael Abrams (Valley of Doves)
In this episode of The Rumors Are True, Jeremy sits down with Michael Abrams of Valley of Doves, a standout artist from the influential indie label Fever Ltd., for a thoughtful and engaging conversation about music, creativity, and the stories behind the songs. Michael reflects on the origins ...
Pharmaceutical Executive Daily: FDA Approves Expanded Indication for Camzyos
Regeneron and Sanofi expand their antibody alliance with four new drug candidates, FDA approves Camzyos for adolescents with obstructive hypertrophic cardiomyopathy, and Michael Abrams questions digital health's savings claims to employers.
